SIROLIMUS - ANVISA Registration 80146502270

Access comprehensive regulatory information for SIROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502270 and manufactured by manufacturer not specified. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Aug 10, 2030.

This page provides complete technical specifications for 3 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including ABBOTT LABORATORIES DIAGNOSTICS DIVISION, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
4 Competitors
80146502270
3 Related Devices
Registration Details
ANVISA Registration Number: 80146502270
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (3)

FamĂ­lia Alinity i Sirolimus
Risk Class III

Registration Details

80146502270

25351261448202009

56998701000116

Company Information

Dates and Status

Aug 10, 2020

10/08/2030

09/18/2025 19:00:01

FamĂ­lia Alinity i Sirolimus
Risk Class III

Registration Details

80146502270

25351261448202009

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

Aug 10, 2020

10/08/2030

09/18/2025 19:00:01

FamĂ­lia Alinity i Sirolimus
Risk Class III

Registration Details

80146502270

25351261448202009

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

Aug 10, 2020

10/08/2030

09/18/2025 19:00:01